Genetic Signatures (Australia) Performance
| GSS Stock | 0.24 0.00 0.00% |
Genetic Signatures has a performance score of 1 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 2.77, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Genetic Signatures will likely underperform. Genetic Signatures right now retains a risk of 8.37%. Please check out Genetic Signatures total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to decide if Genetic Signatures will be following its current trending patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Genetic Signatures are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Genetic Signatures may actually be approaching a critical reversion point that can send shares even higher in January 2026. ...more
1 | Genetic Signatures Ltd Announces 2025 Annual General Meeting Details - TipRanks | 10/15/2025 |
2 | Genetic Signatures Reports Regional Success of EasyScreen Gastrointestinal Parasite Detection Kit - new.smallcaps.com.au | 10/22/2025 |
3 | Genetic Signatures Updates CEO Remuneration Package - TipRanks | 11/06/2025 |
4 | Health Check Genetic Signatures holds course as Island climbs on FDA breakthrough - Stockhead | 11/17/2025 |
| Begin Period Cash Flow | 36.3 M | |
| Total Cashflows From Investing Activities | -24.3 M | |
| Free Cash Flow | -13.2 M |
Genetic |
Genetic Signatures Relative Risk vs. Return Landscape
If you would invest 26.00 in Genetic Signatures on September 30, 2025 and sell it today you would lose (2.00) from holding Genetic Signatures or give up 7.69% of portfolio value over 90 days. Genetic Signatures is generating 0.1461% of daily returns assuming 8.3715% volatility of returns over the 90 days investment horizon. Simply put, 75% of all stocks have less volatile historical return distribution than Genetic Signatures, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Genetic Signatures Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genetic Signatures' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Genetic Signatures, and traders can use it to determine the average amount a Genetic Signatures' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0174
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | GSS |
| Negative Returns |
Estimated Market Risk
| 8.37 actual daily | 75 75% of assets are less volatile |
Expected Return
| 0.15 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Genetic Signatures is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genetic Signatures by adding it to a well-diversified portfolio.
Genetic Signatures Fundamentals Growth
Genetic Stock prices reflect investors' perceptions of the future prospects and financial health of Genetic Signatures, and Genetic Signatures fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Genetic Stock performance.
| Return On Equity | -0.36 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (1.02) % | ||||
| Operating Margin | (0.48) % | ||||
| Current Valuation | 24.01 M | ||||
| Shares Outstanding | 227.14 M | ||||
| Price To Book | 1.09 X | ||||
| Price To Sales | 2.76 X | ||||
| Revenue | 15.9 M | ||||
| Gross Profit | 10.51 M | ||||
| EBITDA | (16.08 M) | ||||
| Net Income | (20.1 M) | ||||
| Total Debt | 791 K | ||||
| Book Value Per Share | 0.22 X | ||||
| Cash Flow From Operations | (12.29 M) | ||||
| Earnings Per Share | (0.09) X | ||||
| Total Asset | 54.63 M | ||||
| Retained Earnings | (87.11 M) | ||||
About Genetic Signatures Performance
Assessing Genetic Signatures' fundamental ratios provides investors with valuable insights into Genetic Signatures' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Genetic Signatures is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Genetic Signatures is entity of Australia. It is traded as Stock on AU exchange.Things to note about Genetic Signatures performance evaluation
Checking the ongoing alerts about Genetic Signatures for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Genetic Signatures help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Genetic Signatures had very high historical volatility over the last 90 days | |
| Genetic Signatures has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 15.9 M. Net Loss for the year was (20.1 M) with profit before overhead, payroll, taxes, and interest of 10.51 M. | |
| Genetic Signatures generates negative cash flow from operations | |
| About 56.0% of the company shares are owned by institutional investors |
- Analyzing Genetic Signatures' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Genetic Signatures' stock is overvalued or undervalued compared to its peers.
- Examining Genetic Signatures' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Genetic Signatures' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Genetic Signatures' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Genetic Signatures' stock. These opinions can provide insight into Genetic Signatures' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Genetic Stock Analysis
When running Genetic Signatures' price analysis, check to measure Genetic Signatures' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Signatures is operating at the current time. Most of Genetic Signatures' value examination focuses on studying past and present price action to predict the probability of Genetic Signatures' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Signatures' price. Additionally, you may evaluate how the addition of Genetic Signatures to your portfolios can decrease your overall portfolio volatility.